Lam Research (NASDAQ:LRCX - Get Free Report) had its price target raised by equities research analysts at Deutsche Bank Aktiengesellschaft from $150.00 to $160.00 in a report released on Thursday,MarketScreener reports. The brokerage presently has a "buy" rating on the semiconductor company's stock. Deutsche Bank Aktiengesellschaft's price objective would indicate a potential upside of 5.49% from the stock's current price.
Several other research firms also recently issued reports on LRCX. UBS Group set a $165.00 price objective on shares of Lam Research and gave the stock a "buy" rating in a report on Thursday. JPMorgan Chase & Co. upped their price target on Lam Research from $113.00 to $165.00 and gave the company an "overweight" rating in a report on Thursday. B. Riley lifted their price objective on Lam Research from $160.00 to $175.00 and gave the stock a "buy" rating in a report on Monday, October 20th. Evercore ISI upped their target price on Lam Research from $115.00 to $170.00 and gave the company an "outperform" rating in a research note on Thursday. Finally, Susquehanna boosted their price target on shares of Lam Research from $135.00 to $200.00 and gave the company a "positive" rating in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and eight have issued a Hold rating to the company's stock. Based on data from MarketBeat, Lam Research currently has a consensus rating of "Moderate Buy" and an average price target of $147.57.
Get Our Latest Report on LRCX
Lam Research Stock Up 2.8%
Shares of Lam Research stock opened at $151.68 on Thursday. Lam Research has a 12-month low of $56.32 and a 12-month high of $153.70. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The stock has a 50 day moving average price of $123.23 and a two-hundred day moving average price of $99.60. The stock has a market capitalization of $191.27 billion, a P/E ratio of 33.41, a PEG ratio of 1.76 and a beta of 1.84.
Lam Research (NASDAQ:LRCX - Get Free Report) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter last year, the firm posted $0.86 EPS. The business's quarterly revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities analysts expect that Lam Research will post 3.71 earnings per share for the current year.
Insider Buying and Selling
In other news, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the sale, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.31% of the company's stock.
Institutional Investors Weigh In On Lam Research
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Norges Bank acquired a new position in shares of Lam Research during the second quarter worth approximately $1,894,585,000. Vanguard Group Inc. raised its position in shares of Lam Research by 6.9% during the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company's stock worth $9,389,358,000 after acquiring an additional 8,364,375 shares during the last quarter. Nuveen LLC bought a new position in Lam Research in the first quarter valued at approximately $604,344,000. JPMorgan Chase & Co. grew its holdings in Lam Research by 14.4% during the 2nd quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company's stock worth $3,954,188,000 after acquiring an additional 5,102,589 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its stake in shares of Lam Research by 99.7% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company's stock valued at $417,242,000 after purchasing an additional 2,864,863 shares during the period. Institutional investors and hedge funds own 84.61% of the company's stock.
About Lam Research
(
Get Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.